Canadian Institutes of Health Research
570,556 snapshots · latest May 3, 2026
Homepage:https://cihr-irsc.gc.ca/
Archive explorer
Browse & search snapshots
Important note
Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.
For background on coverage and capture methods, see Methods & coverage.
Browse archived sites
Health Canada
386,223 snapshots · latest Apr 14, 2026
Public Health Agency of Canada
243,880 snapshots · latest Apr 28, 2026
Notice: Prescription Drug List (PDL): Multiple additions March 12, 2018 Our file number: 18-102696-288 The purpose of this Notice of Amendment is to notify about the additions of avelumab, dupilumab, guselkumab, lifitegrast, lotilaner, olaratumab, sebelipase alfa, semaglutide,…
Notice: Prescription Drug List (PDL): Multiple Additions Janurary 4, 2018 Our reference number: 17-114235-356 The purpose of this Notice of Amendment is to notify about the additions of durvalumab, glycopyrrolate, letermovir, migalastat, netupitant/palonosetron hydrochloride to…
Notice - Prescription Drug List (PDL): Multiple Additions (PDF Version - 305 K) October 19, 2017 Our file number: 17-110956-588 The purpose of this Notice of Amendment is to notify about the additions of Defibrotide sodium, Glecaprevir/Pibrentasvir, Midostaurin, Ocrelizumab and…
Notice - Prescription Drug List (PDL): Hydroquinone August 29, 2017 Our file number: 17-109315-912 The purpose of this Notice of Intent to Amend is to notify that Health Canada will add certain hydroquinone products to the Prescription Drug List (PDL). Only the Human part of the…
Questions and Answers - Naloxone 1. What is naloxone? Naloxone is a drug that prevents or reverses the effects of opioids, including respiratory depression, sedation, and hypotension. It can be used in emergency situations to reduce opioid overdose (OD) deaths. 2. How is naloxone…
Notice - Prescription Drug List (PDL): Multiple additions May 19, 2017 Our file number: 17-105533-859 The purpose of this Notice of Amendment is to notify the additions of atezolizumab, eliglustat and obeticholic acid to the Human and Veterinary Prescription Drug Lists (PDL).…
Notice - Prescription Drug List (PDL): Multiple additions April 21, 2017 Our file number: 17-104599-650 The purpose of this Notice of Amendment is to notify the additions of Brexpiprazole, Necitumumab, Pegaspargase, and Vernakalant hydrochloride to the Human and Veterinary…
Notice - Prescription Drug List (PDL): Multiple additions March 29, 2017 Our file number: 17-103107-174 The purpose of this Notice of Amendment is to notify the additions of Eluxadoline, Peramivir, Propiverine hydrochloride and Sarilumab to the Human and Veterinary Prescription…
Notice: Prescription Drug List (PDL): Multiple Additions [2017-06-23] June 23, 2017 Our file number: 17-106422-736 The purpose of this Notice of Amendment is to notify the additions of Lixisenatide, Ozenoxacin and Reslizumab to the Human and Veterinary Prescription Drug Lists…
Notice of Consultation - Prescription Drug List (PDL): Veterinary and Human Antimicrobials Notice of Consultation Prescription Drug List (PDL): Veterinary and Human Antimicrobials July 5, 2017 Our file number: 17-106962-472 This Notice of Consultation provides an opportunity to…
Early release: coverage and features are still expanding.
